» Articles » PMID: 15014986

Microcystic Tubulopapillary Carcinoma of the Pancreas: a New Tumor Entity?

Overview
Journal Virchows Arch
Date 2004 Mar 12
PMID 15014986
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

An unusual pancreatic tumor with microcystic and tubulopapillary features was observed in a 53-year-old woman. The tumor presented as a large, focally cystic mass in the head of the pancreas, which compressed the surrounding structures. The histological and immunohistochemical analysis revealed a neoplasm that could not be assigned to any of the known pancreatic tumor types. At the molecular level, the tumor showed inactivation of the DPC4/SMAD4 gene, deletion of exon 1 of the p16(INK4A) gene and a point mutation at codon 34 (GGA>AGA) of beta-catenin. Transcriptional profiling analyses and subsequent correspondence cluster analysis demonstrated that the transcriptional profile of the tumor differed distinctly from that of ductal adenocarcinomas, pancreatic cystic tumors and normal pancreatic tissues. These data suggest that the neoplasm most likely represents a new pancreatic tumor entity, which we would like to refer to as microcystic tubulopapillary tumor.

Citing Articles

Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: a distinct entity among pancreatic tumors.

Paolino G, Esposito I, Hong S, Basturk O, Mattiolo P, Kaneko T Histopathology. 2022; 81(3):297-309.

PMID: 35583805 PMC: 9544156. DOI: 10.1111/his.14698.


[Intraductal neoplasms of the pancreas].

Esposito I, Haberle L, Yavas A, Kraft A, Gaida M Pathologe. 2021; 42(5):472-483.

PMID: 34402978 DOI: 10.1007/s00292-021-00966-1.


Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.

Basturk O, Berger M, Yamaguchi H, Adsay V, Askan G, Bhanot U Mod Pathol. 2017; 30(12):1760-1772.

PMID: 28776573 DOI: 10.1038/modpathol.2017.60.


Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.

Basturk O, Adsay V, Askan G, Dhall D, Zamboni G, Shimizu M Am J Surg Pathol. 2016; 41(3):313-325.

PMID: 27984235 PMC: 5309137. DOI: 10.1097/PAS.0000000000000782.


Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.

Schlitter A, Jang K, Kloppel G, Saka B, Hong S, Choi H Mod Pathol. 2015; 28(9):1249-64.

PMID: 26111977 DOI: 10.1038/modpathol.2015.61.


References
1.
Robbins 2nd E, Franceschi D, Barkin J . Solitary metastatic tumors to the pancreas: a case report and review of the literature. Am J Gastroenterol. 1996; 91(11):2414-7. View

2.
Wilentz R, Su G, Dai J, Sparks A, Argani P, Sohn T . Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Am J Pathol. 2000; 156(1):37-43. PMC: 1868651. DOI: 10.1016/S0002-9440(10)64703-7. View

3.
Zgraggen K, Fernandez-Del Castillo C, Rattner D, Sigala H, Warshaw A . Metastases to the pancreas and their surgical extirpation. Arch Surg. 1998; 133(4):413-7; discussion 418-9. DOI: 10.1001/archsurg.133.4.413. View

4.
Beissbarth T, Fellenberg K, Brors B, Boer J, Hauser N, Scheideler M . Processing and quality control of DNA array hybridization data. Bioinformatics. 2001; 16(11):1014-22. DOI: 10.1093/bioinformatics/16.11.1014. View

5.
Abraham S, Klimstra D, Wilentz R, Yeo C, Conlon K, Brennan M . Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002; 160(4):1361-9. PMC: 1867216. DOI: 10.1016/s0002-9440(10)62563-1. View